CAS: 551-08-6; 3-Butylideneisobenzofuran-1(3H)-One

该化合物是一种天然产生的有机化合物,属于二硫代物,主要存在于诸如大灰素和安赫利卡物种等植物中,其特征为:二氟二烯三烯基物质组,附于二氟二烯基,具有独特的芳香特性;该化合物具有潜在的生物活性效应,包括抗炎和...

结构式图片

相似化合物

94704-89-9 90965-68-7 17369-59-4

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号201230-82-2 carbon monoxide | CAS号79784-61-5 2'-bromovalerop... | CAS号85-44-9 苯酐 | CAS号109-52-4 正戊酸 | CAS号2082-59-9 戊酸酐 | CAS号550-37-8 2-戊酰基苯甲酸 | CAS号3431-67-2 butane,cadmium(2+) | CAS号64-18-6 甲酸 | CAS号20871-40-3 3-butylideneiso... | CAS号122654-56-2 3-butyl-2,3-dih... | CAS号76681-73-7 (3E)-3-Butylide... | CAS号72917-31-8 Z-亚丁基苯酞 | CAS号550-37-8 2-戊酰基苯甲酸

合成工艺路线路线简述

  • 合成目标产物 3-Butylidenephthalide 主要起始原料 Phthalic Anhydride And Valeric Anhydride
  • (文献来源)合成步骤主要原料 Phthalic Anhydride 和 Valeric Anhydride
3-丁基-3-羟基-2-苯并呋喃-1-酮置于对甲苯磺酸体系中,用 甲苯 作为反应溶剂,以3.3 G的收率获得产物正丁亚基邻苯二甲酰胺
参考文献:苯酞内酯与氟康唑及其新类似物的协同作用作为限制唑类药物治疗念珠菌病的因素
标题:苯酞内酯与氟康唑及其新类似物的协同作用作为限制唑类药物治疗念珠菌病的因素
摘要:近年来,白色念珠菌和其他病原酵母菌对唑类抗真菌药物的耐药性迅速增加,是临床治疗中的一个重要问题.目前的药理学知识状况排除了唑类药物的撤回,因为尚未开发出其他活性物质可以有效替代它们.因此,抗酵母策略之一可能是依靠天然化合物和唑类药物的协同作用的疗法,限制唑类药物对抗念珠菌病的使用.体外进行的协同测定用于评估药物相互作用分数抑制浓度指数.氟康唑 (1) 和三种与芹菜植物中天然存在的合成内酯相同的协同作用-3-正丁基苯酞 (2),3-正亚丁基苯酞 (3),3-正丁基-4,5,6,7-四氢苯酞 (4)-针对白色念珠菌atcc 10231,白色念珠菌atcc 2091 和吉里蒙念珠菌kkp 3390 的性能分别与各个化合物的性能进行了比较.氟康唑 (1) 的 Mic 90 (抑制酵母生长 90% 的抑菌物质的量(以 µg/ml 为单位))测定为 5.96-6.25 µg/ml,内酯2-4
DOI:10.3390/antibiotics11111500

海关参考信息

专利信息


专利号:US-10682335-B2
优先权日:2014-07-28
标题 :Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same
发明人:SU HONG-LIN; CHANG CHIA-YU; HWANG SHIAW-MIN; Lu huai-en; HARN HORNG-JYH; LIN SHINN-ZONG; LAI PING-SHAN
权利人:EVERFRONT BIOTECH INC
摘要:The present invention discloses use of butylidenephthalide (Bdph), a method of using the same, and a method for preparing a pharmaceutical composition containing the same. Because Bdph has the capability of promoting the hair growth and reducing the β-amyloid protein (Aβ) level in nerve cells, the efficacy of improving the health and appearance of a subject can be achieved by administrating an effective amount of Bdph to the subject. Specifically, the Bdph has the efficacy of preventing or treating neurodegenerative diseases such as Alzheimer's disease caused by excessive build up of Aβ in the cells, and as an active ingredient in a topical composition, the Bdph is effective in promoting the hair growth at the site where the Bdph is administered. Furthermore, the method for preparing a pharmaceutical composition containing Bdph comprises preparing the pharmaceutical composition through an organic synthesis reaction, wherein the Bdph is coated with a polymeric material such as F127 by covalent bonding of the polymeric material with the Bdph, thereby achieving the effect of reducing the cytotoxicity of the pharmaceutical composition for an organism.

专利号:US-12403116-B2
优先权日:2022-03-04
标 题:Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof
发明人:SUN XIAOBO; TIAN YU; SUN XIAO
权利人:CHINESE ACADEMY OF MEDICAL SCIENCES INST OF MEDICINAL PLANT DEVELOPMENT
摘要:Disclosed are a hydroxypentyl benzoic acid diester compound, a method preparing the same, and an application of the same. This application uses a combination principle, on the one hand, the medicine concentration of butylphthalide in cerebral vessels is improved through a function of promoting the medicine to penetrate through a blood-brain barrier of dexborneol, and a multi-target multi-channel synergistic brain protection effect of the medicine is exerted; on the other hand, the treatment effect of dexborneol on cerebral ischemia is exerted. Anti-cerebral ischemia in-vivo pharmacodynamic activity evaluation is carried out on the synthesized compound, a high-activity candidate medicine is obtained, and industrial production can be achieved through the synthesis method.

专利号:US-10543191-B2
优先权日:2017-01-25
标题:Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same
发明人:SU HONG-LIN; CHANG CHIA-YU; HWANG SHIAW-MIN; Lu huai-en; HARN HORNG-JYH; LIN SHINN-ZONG; LAI PING-SHAN
权利人:EJIA BIOTECHNOLOGY CO LTD
摘要:The present invention discloses use of butylidenephthalide (Bdph), a method of using the same, and a method for preparing a pharmaceutical composition containing the same. Because Bdph has the capability of promoting the hair growth and reducing the β-amyloid protein (Aβ) level in nerve cells, the efficacy of improving the health and appearance of a subject can be achieved by administrating an effective amount of Bdph to the subject. Specifically, the Bdph has the efficacy of preventing or treating neurodegenerative diseases such as Alzheimer's disease caused by excessive build up of Aβ in the cells, and as an active ingredient in a topical composition, the Bdph is effective in promoting the hair growth at the site where the Bdph is administered. Furthermore, the method for preparing a pharmaceutical composition containing Bdph comprises preparing the pharmaceutical composition through an organic synthesis reaction, wherein the Bdph is coated with a polymeric material such as F127 by covalent bonding of the polymeric material with the Bdph, thereby achieving the effect of reducing the cytotoxicity of the pharmaceutical composition for an organism.

专利号:US-7348034-B2
优先权日:2005-03-07
标题 :Plant based formulations for improving skin moisture, texture, and appearance
发明人:MURRAY MARY A; CRAWFORD AARON W; FAST DAVID J; DONG DORA; HUANG MICHAEL; CONNOR LYNNE MARIE
权利人:ACCESS BUSINESS GROUP INT LLC
摘要:The present invention relates to formulations of ingredients that are useful for improving the appearance, texture and/or moisture of skin. In particular, the formulations of the present invention stimulate collagen, elastin, and lipid synthesis and/or inhibit or minimize the loss of collagen, elastin, and lipids in the skin. Additionally, the formulations of the present invention inhibit matrix metalloproteases, such as MMP-1, MMP-9, collagenase, or elastase.

专利号:CN-217511828-U
优先权日:2022-04-21
标题:A kind of reactor for 3-butylidenephthalide synthesis

专利号:CN-111196794-A
优先权日:2020-01-17
标题:Synthesis method of food additive butylidene phthalide and its application in seasoning
石家庄多维化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.dowechem.com/
电话: 0311-89805679 +86-13463963265👤
📞石家庄多维化工有限公司 ⚠️参考联系方式

销售电话:0311-89805679 +86-13463963265
邮箱:sell@dowechem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海泰矶林实业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.tajilin.com
企业联系电话:021-50630626,18964684208👤
📞上海泰矶林实业有限公司 ⚠️参考联系方式
联系人:销售部
电话:021-50630626,18964684208
手机:18964684208
传真:021-50563898
邮箱:sales001@tajilin.com
通信地址: 上海市松江区沈砖公路5808号14幢5层536B室
邮编: 201619
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市松江区沈砖公路5808号14幢5层536B室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
杭州绿天生物技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.greenskybio.com
电话: 0571-85303241👤
📞杭州绿天生物技术有限公司 ⚠️参考联系方式

销售电话:0571-85303241
邮箱:sales@greenskybio.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1186/1472-6882-14-144
摘要:Yeh T, Hsu C, Yang S, Hsu M, Liu J. Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway. BMC Complementary Medicine and Therapies. 2014 May 03;14(1):144. doi: 10.1186/1472-6882-14-144.
参考文献:10.2147/ijn.s85790
摘要:Lin YL, Chang KF, Huang XF, Hung CL, Chen SC, Chao WR, Liao KW, Tsai NM. Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme. Int J Nanomedicine. 2015;10():6009–20.
参考文献:10.1007/978-3-319-45618-8_2
摘要:León A, Del-Ángel M, Ávila JL, Delgado G. Phthalides: Distribution in Nature, Chemical Reactivity, Synthesis, and Biological Activity. Prog Chem Org Nat Prod. 2017;104():127–246. doi: 10.1007/978-3-319-45618-8_2.
参考文献:10.1007/s13318-018-0476-8
摘要:Wu H, Wang X, Deng J, Quan S, Wang Q, Li W. Pharmacokinetic Profiling of Butylidenephthalide and Alisol B in Danggui-Shaoyao-San in Rats. European Journal of Drug Metabolism and Pharmacokinetics. 2018 Apr 27;43(6):645–53. doi: 10.1007/s13318-018-0476-8.
参考文献:10.1021/jf020293a
摘要:Kwon JH, Ahn YJ. Acaricidal activity of butylidenephthalide identified in Cnidium officinale rhizome against dermatophagoides farinae and dermatophagoides pteronyssinus (Acari: Pyroglyphidae). J Agric Food Chem. 2002 Jul 31;50(16):4479–83. doi: 10.1021/jf020293a.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知